$2.27T
Total marketcap
$127.47B
Total volume
BTC 49.81%     ETH 15.73%
Dominance

Allergy Therapeutics plc HHU.F Stock

0.03 EUR {{ price }} -5.084744% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
158.99M EUR
LOW - HIGH [24H]
0.03 - 0.03 EUR
VOLUME [24H]
5K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.07 EUR

Allergy Therapeutics plc Price Chart

Allergy Therapeutics plc HHU.F Financial and Trading Overview

Allergy Therapeutics plc stock price 0.03 EUR
Previous Close 0.05 EUR
Open 0.05 EUR
Bid 0 EUR x N/A
Ask 0 EUR x N/A
Day's Range 0.05 - 0.05 EUR
52 Week Range 0.05 - 0.23 EUR
Volume 20K EUR
Avg. Volume 0 EUR
Market Cap 48.21M EUR
Beta (5Y Monthly) 0.950191
PE Ratio (TTM) N/A
EPS (TTM) -0.07 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

HHU.F Valuation Measures

Enterprise Value 20.61M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.66248554
Price/Book (mrq) 0.7916667
Enterprise Value/Revenue 0.283
Enterprise Value/EBITDA -2.511

Trading Information

Allergy Therapeutics plc Stock Price History

Beta (5Y Monthly) 0.950191
52-Week Change -78.98%
S&P500 52-Week Change 20.43%
52 Week High 0.23 EUR
52 Week Low 0.05 EUR
50-Day Moving Average 0.05 EUR
200-Day Moving Average 0.1 EUR

HHU.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 679.11M
Float 95.45M
Short Ratio N/A
% Held by Insiders 123.30%
% Held by Institutions 6.23%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) June 30, 2022
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin -18.93%
Operating Margin (ttm) -17.0030%
Gross Margin 68.03%
EBITDA Margin -11.27%

Management Effectiveness

Return on Assets (ttm) -9.56%
Return on Equity (ttm) -31.69%

Income Statement

Revenue (ttm) 72.77M EUR
Revenue Per Share (ttm) 0.11 EUR
Quarterly Revenue Growth (yoy) -20.59%
Gross Profit (ttm) 49.51M EUR
EBITDA -8207000 EUR
Net Income Avi to Common (ttm) -13776000 EUR
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 20.52M EUR
Total Cash Per Share (mrq) 0.03 EUR
Total Debt (mrq) 10.53M EUR
Total Debt/Equity (mrq) 27.42 EUR
Current Ratio (mrq) 2.381
Book Value Per Share (mrq) 0.06

Cash Flow Statement

Operating Cash Flow (ttm) -14372000 EUR
Levered Free Cash Flow (ttm) -11695250 EUR

Profile of Allergy Therapeutics plc

Country Germany
State N/A
City Worthing
Address Dominion Way
ZIP BN14 8SA
Phone 44 1903 844 700
Website https://www.allergytherapeutics.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 600

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Acarovac Plus, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Q&A For Allergy Therapeutics plc Stock

What is a current HHU.F stock price?

Allergy Therapeutics plc HHU.F stock price today per share is 0.03 EUR.

How to purchase Allergy Therapeutics plc stock?

You can buy HHU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Allergy Therapeutics plc?

The stock symbol or ticker of Allergy Therapeutics plc is HHU.F.

Which industry does the Allergy Therapeutics plc company belong to?

The Allergy Therapeutics plc industry is Drug Manufacturers-Specialty & Generic.

How many shares does Allergy Therapeutics plc have in circulation?

The max supply of Allergy Therapeutics plc shares is 5.68B.

What is Allergy Therapeutics plc Price to Earnings Ratio (PE Ratio)?

Allergy Therapeutics plc PE Ratio is now.

What was Allergy Therapeutics plc earnings per share over the trailing 12 months (TTM)?

Allergy Therapeutics plc EPS is -0.07 EUR over the trailing 12 months.

Which sector does the Allergy Therapeutics plc company belong to?

The Allergy Therapeutics plc sector is Healthcare.